Literature DB >> 6346616

Monoclonal antibody toxin conjugates for experimental graft-versus-host disease prophylaxis. Reagents selectively reactive with T cells and not murine stem cells.

D A Vallera, R J Youle, D M Neville, C C Soderling, J H Kersey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6346616     DOI： 10.1097/00007890-198307000-00015

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  3 in total

Review 1.  Monoclonal antibodies. Future potential in cancer chemotherapy.

Authors:  C Kosmas; H Kalofonos; A A Epenetos
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

2.  Peptides and proteins as drugs.

Authors:  B L Ferraiolo; L Z Benet
Journal:  Pharm Res       Date:  1985-07       Impact factor: 4.200

Review 3.  Bifunctional recombinant proteins in cancer therapy: cell penetrating peptide aptamers as inhibitors of growth factor signaling.

Authors:  Claudia Buerger; Bernd Groner
Journal:  J Cancer Res Clin Oncol       Date:  2003-09-11       Impact factor: 4.553
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.